Stockreport

High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy [Yahoo! Finance]

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF of nusinersen in treatment-naive participants and those transitioning from the currently approved 12mg dose regimen Final European Commission decision expected in Janu [Read more]